Pacific Biosciences Of California | PACB - Sales Revenues


Pacific Biosciences Of California reported $44.64M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agilent USD 1.84B 37M Mar/2026
Bruker USD 823.4M 153.8M Mar/2026
Danaher USD 5.95B 890M Mar/2026
General Electric Aerospace USD 11.6B 270M Mar/2026
Illumina USD 1.09B 70M Mar/2026
Myriad Genetics USD 200.4M 9.4M Mar/2026
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quidel USD 620M 104M Mar/2026
Revvity USD 711M 61.06M Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Standard Biotools USD 21.1M 2.7M Mar/2026
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Waters USD 1.27B 338M Mar/2026